In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion

Despite the poor prognosis associated with myelomeningocele (MMC), the options for prenatal treatments are still limited. Recently, fetal cellular therapy has become a new option for treating birth defects, although the therapeutic effects and mechanisms associated with such treatments remain unclea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: Abe, Yushi, Ochiai, Daigo, Masuda, Hirotaka, Sato, Yu, Otani, Toshimitsu, Fukutake, Marie, Ikenoue, Satoru, Miyakoshi, Kei, Okano, Hideyuki, Tanaka, Mamoru
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Fetal and Neonatal Stem Cells
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811697/
https://ncbi.nlm.nih.gov/pubmed/31407874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.19-0002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados